#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pulmonary hypertension Carcinoid tumour Isodicentric chromosome 15 syndrome Metastatic gastric cancer Cardiomyopathy Fibrodysplasia ossificans progressiva Oesophageal atresia Drug eruption Chronic lymphocytic leukaemia refractory Myeloid leukaemia Lung adenocarcinoma Thalassaemia Polymyositis Neurodermatitis Malignant neoplasm of choroid More trials…

    Learn about Rare Diseases

    KBG syndrome – Treatment Choroid melanoma Mastocytosis – Diagnostics Atypical haemolytic uraemic syndrome – Life with Disease Activated PI3 kinase delta syndrome – Trials in Disease Anaplastic thyroid cancer – Treatment Rhabdoid tumour – Life with Disease Breast angiosarcoma metastatic – Treatment Gaucher’s disease type I – Basic Information Ewing’s sarcoma recurrent – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Flortaucipir (18F) Capecitabine Amivantamab Sirexatamab Wve-006 Bms-986442 Ecoo15 VG801-2 Esk-001 [18F]Mc225 Eptacog Beta (Activated) Blu-222 A/H1N1 INFLUENZA VACCINE Rezvilutamide DAPIGLUTIDE Oregovomab Ifezuntirgene Inilparvovec CYCLIZINE HYDROCHLORIDE Lisdexamfetamine Dimesylate Pegvaliase More therapies…

    Learn about Your Condition

    Papulopustular rosacea Corticobasal degeneration Pyelonephritis acute Arrhythmia supraventricular Affective disorder Mucopolysaccharidosis Cerebral haemorrhage Medulloblastoma recurrent Coronary artery disease Mucopolysaccharidosis II Alveolar proteinosis Colon cancer Nephropathy Ataxia telangiectasia Pancreatic failure More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Mitotane Alone or with Cisplatin and Etoposide for Patients with High-Risk Adrenocortical Carcinoma After Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Adrenocortical carcinoma
    Investigated Drugs:
    • Mitotane
    • Cisplatin
    • Etoposide
    France Germany Sweden

  • Comparing Spironolactone and Eplerenone for Patients with Heart Failure and Reduced Ejection Fraction

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac failure
    Investigated Drugs:
    • Eplerenone
    • Spironolactone
    Denmark

  • Study on the Effects of THC 2% Oil for Patients with Chronic Neuropathic Pain

    Recruiting

    2 1
    Investigated Diseases:
    • Neuralgia
    Investigated Drugs:
    • Dronabinol
    The Netherlands

  • Study on Etrasimod for Adolescents with Moderate to Severe Ulcerative Colitis

    Recruiting

    2 1 1
    Investigated Drugs:
    • Etrasimod Arginine
    Austria Belgium Poland Slovakia Spain

  • Study of Aztreonam-Avibactam and Metronidazole for Children with Serious Gram-Negative Bacterial Infections

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Bacterial infection
    • Infection
    • Sepsis
    Investigated Drugs:
    • Amikacin
    • Avibactam Sodium
    • Colistimethate Sodium
    Czechia Greece Hungary Spain

  • Study on the Effectiveness of High-Flow Oxygen Therapy for Migraine Attacks in Emergency Department Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    • Migraine without aura
    Investigated Drugs:
    • Oxygen
    France
Previous Page
1 … 575 576 577 578 579 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!